NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

A boost for the category, and perhaps even a change in the way products are marketed, is anticipated based on research ...

Oxford Medical Products today announces additional three-month clinical trial results for Sirona, a weight-loss treatment targeting people who are overweight or have class I obesity (BMI 25-35) and ...

Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving Solutions Surge Driven by Ozempic and Zepbound Prescription Savings Opportunities Combined with Seasonal Health ...

HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

As the demand for GLP-1 drugs continues to rise and access remains limited, the proliferation of counterfeit products is likely to persist. As Mackey warns: "It's just the beginning of a long ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of ... that are hoping to hit on effective 'me-too' products that can make a dent in the substantial ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...